Unjoni Ewropea - Malti - EMA (European Medicines Agency)

recordati rare diseases - betaine anidru - homocystinurja - oħra tal-passaġġ alimentari u tal-metaboliżmu-prodotti, - adjunctive treatment of homocystinuria, involving deficiencies or defects in:cystathionine beta-synthase (cbs);5,10-methylene-tetrahydrofolate reductase (mthfr);cobalamin cofactor metabolism (cbl). cystadane should be used as supplement to other therapies such as vitamin b6 (pyridoxine), vitamin b12 (cobalamin), folate and a specific diet.

Unjoni Ewropea - Malti - EMA (European Medicines Agency)

serb sa - betaine - homocystinurja - oħra tal-passaġġ alimentari u tal-metaboliżmu-prodotti, - amversio is indicated as adjunctive treatment of homocystinuria, involving deficiencies or defects in:•         cystathionine beta-synthase (cbs),•         5,10 methylene tetrahydrofolate reductase (mthfr),•         cobalamin cofactor metabolism (cbl).

Unjoni Ewropea - Malti - EMA (European Medicines Agency)

medac gesellschaft fuer klinische spezialpraeparate mbh - asparaginasa - leukimija limfoblastika taċ-Ċelluli prekursuri-linfoma - aġenti antineoplastiċi - spectrila huwa indikat bħala komponent ta 'terapija ta' kombinazzjoni antineoplastika għat-trattament ta 'lewkimja limfoblastika akuta (all) f'pazjenti pedjatriċi minn twelid sa 18-il sena u adulti.

Unjoni Ewropea - Malti - EMA (European Medicines Agency)

agios netherlands b.v. - mitapivat sulfate - genetic diseases, inborn; anemia, hemolytic - other hematological agents - pyrukynd is indicated for the treatment of pyruvate kinase deficiency (pk deficiency) in adult patients (see section 4.

Unjoni Ewropea - Malti - EMA (European Medicines Agency)

recordati netherlands b.v. - tienzanib - karċinoma, Ċellula renali - aġenti antineoplastiċi - fotivda huwa indikat għall-ewwel trattament linja ta ' l-adulti pazjenti b ' karċinoma taċ-ċelluli renali avvanzati (rcc) u għall-pazjenti adulti li huma vegfr u mtor il-mogħdija inhibitor-naïve wara progressjoni tal-marda wara t-trattament minn qabel waħda ma cytokine terapija għall rcc avvanzati. it-trattament ta ' karċinoma taċ-ċellola renali.

Unjoni Ewropea - Malti - EMA (European Medicines Agency)

ucb pharma ltd - sodium oxybate - cataplexy; narcolepsy - drogi oħra tas-sistema nervuża - kura tan-narkolessija bil-kataplessija f'pazjenti adulti.

Unjoni Ewropea - Malti - EMA (European Medicines Agency)

nanotherapeutics bohumil, s.r.o. - whole virion influenza vaccine, inactivated containing antigen of strain a/california/07/2009 (h1n1)v - disease outbreaks; influenza, human; immunization - vaċċini - profilassi tal-influwenza kkawżata mill-virus a (h1n1) v 2009. celvapan ma għandu jintuża skont il-gwida uffiċjali.

Unjoni Ewropea - Malti - EMA (European Medicines Agency)

blueprint medicines (netherlands) b.v. - avapritinib - tumur stromali gastrointestinali - aġenti antineoplastiċi oħra, inibituri tal-proteina kinase - ayvakyt is indicated as monotherapy for the treatment of adult patients with unresectable or metastatic gastrointestinal stromal tumours (gist) harbouring the platelet-derived growth factor receptor alpha (pdgfra) d842v mutation.

Unjoni Ewropea - Malti - EMA (European Medicines Agency)

taiho pharma netherlands b.v. - futibatinib - cholangiocarcinoma - aġenti antineoplastiċi - lytgobi monotherapy is indicated for the treatment of adult patients with locally advanced or metastatic cholangiocarcinoma with a fibroblast growth factor receptor 2 (fgfr2) fusion or rearrangement that have progressed after at least one prior line of systemic therapy.

Unjoni Ewropea - Malti - EMA (European Medicines Agency)

otsuka pharmaceutical netherlands b.v. - cedazuridine, decitabine - lewkimja, myeloid - aġenti antineoplastiċi - inaqovi is indicated as monotherapy for the treatment of adult patients with newly diagnosed acute myeloid leukaemia (aml) who are ineligible for standard induction chemotherapy.